Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Facebook
Tweet
Print
Stephanie Moody, MS
PharPoint Research
Durham, North Carolina, United States
Presentation(s):
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Saturday, November 19, 2022
1:30 PM – 1:42 PM
